The approval of water soluble Aivlosin® for swine respiratory disease in Canada is very encouraging, albeit expected. The approval strengthens Aivlosin®’s presence in North America and follows the US marketing authorisation for the same formulation and indication in swine in July 2017. We continue to believe North America will be one of the key territories for driving growth where Aivlosin® currently has a 11.5% share of the targeted branded market (group is targeting a 25% share). The recent in ....
13 Dec 2017
N+1 Singer - ECO Animal Health Group - Marketing authorisation for Aivlosin® in Canada
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
N+1 Singer - ECO Animal Health Group - Marketing authorisation for Aivlosin® in Canada
ECO Animal Health Group plc (EAH:LON) | 85.0 0 0.0% | Mkt Cap: 57.6m
- Published:
13 Dec 2017 -
Author:
Sheena Berry -
Pages:
3
The approval of water soluble Aivlosin® for swine respiratory disease in Canada is very encouraging, albeit expected. The approval strengthens Aivlosin®’s presence in North America and follows the US marketing authorisation for the same formulation and indication in swine in July 2017. We continue to believe North America will be one of the key territories for driving growth where Aivlosin® currently has a 11.5% share of the targeted branded market (group is targeting a 25% share). The recent in ....